A narrative review on efficacy of homoeopathic medicine Pareira brava in urolithiasis.

Published 24-04-2023
Section Review articles

Authors

  • Anjum Pathan G scholar at Bharati Vidyapeeth deemed university Homoeopathic Medical college and Hospital, Pune, India
  • Sufiya Shahid Mulla Post graduate scholar, Department of Homeopathic Pharmacy, Homeopathic Medical College, Bharati Vidyapeeth Deemed to be University, Pune, India, 411043. India
  • Manisha Prashant Gajendragadkar Head of Department of Homeopathic Pharmacy, Bharati Vidyapeeth (Deemed to be University) Homoeopathic Medical College Hospital & Research Centre, Pune Maharashtra. India

DOI:

https://doi.org/10.7770/safer-V13N2-art3009

Abstract

Urolithiasis orNephrolithiasis commonly known as renal calculi, kidney stones, or urine calculi, are terms used to describe the disease of renal stones. Since many years, mankind has been afflicted with this condition, which, if left untreated, may progress to End Stage Renal Disease (ESRD). The multiple aetiology and risk factors of renal stone disease affect about 12% of the world's population. Understanding the process of stone production is extremely difficult because there are many different types of stones, including calcium oxalate and calcium phosphate. The conventional medical system has used a variety of medications and procedures, including PCNL and ESWL, to treat urolithiasis. However, the rate of recurrence is remains
high. Extracts from plants are now utilized to treat kidney stones. There is evidence that homoeopathic medications are employed as curative therapies as well. One of the treatments that homoeopaths usually recommend for kidney stone disease is Pareira Brava. Therefore, use of homoeopathic intervention is attempted in the current review in an effort to shed insight on the evolutionary changes in stone production technology and to lower the recurrence rate.